This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Neely Wilson, C. Articles by Batra, V. K. Search for Related Content PubMed PubMed Citation Articles by Neely Wilson, C. Articles by Batra, V. K. Social Bookmarking                         What's this?

Lipopolysaccharide binds to and activates A1 adenosine receptors on human pulmonary artery endothelial cells

Endacea, Inc., Research Triangle Park, North Carolina, USA

Vinod K. Batra

Endacea, Inc., Research Triangle Park, North Carolina, USA

Previously,it was reported that A₁ adenosine receptor antagonists prevent endotoxin-inducedacute lung injury and pulmonary arterial endothelial cell damage. In competition radioligand binding experiments in membranes prepared from human pulmonary artery endothelial cells (PAECs), lipopolysaccharides (LPSs) of Escherichia coli, Salmonella typhimurium, Klebsiella pneumoniae, and Pseudomonas aeruginosa displaced the binding of a selective A adenosine receptor antagonist [¹²⁵I]-BWA844U (IC ₅₀ values: 195 ng/ml, 290 ng/ml, 602 ng/ml, and 693¹ ng/ml, respectively)in a dose-dependent, competitive manner. There was no displacement of this radioligand by enterotoxin ( 10 µg/ml), diphosphoryl lipid A ( 10µg/ml), and glycolipids, monosialoganglioside( 1µg/ml), lactocerebroside ( 100µg/ml), or NBD galactocerebroside ( 100 µg/ml). Based on calculated IC values, LPS (E. coli, IC₅₀ 111 ng/ml) _{50 6} displaced the selective A₁ adenosine receptor agonist, [³H]-2-chloro, N -cyclopentyladenosine (CCPA) in human PAECs with a potency profile, CCPA > LPS > 2-phenylaminoadenosine (CV 1808), a selective A₂ adenosine receptor agonist. The potency profile for displacement of the selective A µ ^2a adenosine receptor agonist [ ³H]-CGS 21680 was CV 1808 > CCPA. LPS (E. coli 0.1 pg/ml—10 g/ml) did not displace [³H]-CGS 21680 binding. In human PAECs, IL-6 and TXA₂ release induced by LPS (0—1 µg/ml) or CCPA (0—1 µM) at high doses was significantly reduced by the selective A₁ adenosine receptor antagonist, 8-cyclopentyl-1,3-dipropylxanthine(DPCPX; 1 µM). These data suggest that LPS binds to and activates A₁ adenosine receptors on human PAECs to induce the release of IL-6 and TXA ₂. Activation of A₁ adenosine receptors on human PAECs by LPS, may contribute to the pathophysiology of acute lung injury associated with Gram-negative septicemia and endotoxemia.

Journal of Endotoxin Research, Vol. 8, No. 4, 263-271 (2002)
DOI: 10.1177/09680519020080040301


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?